Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00347828|
Recruitment Status : Unknown
Verified June 2006 by Ophthalmic Consultants of Boston.
Recruitment status was: Active, not recruiting
First Posted : July 4, 2006
Last Update Posted : July 4, 2006
|Condition or disease||Intervention/treatment||Phase|
|Eye Infection Infection||Drug: Moxifloxacin ophthalmic solution 0.5% Drug: Gatifloxacin ophthalmic solution 0.3%||Phase 4|
Topical antibiotics are frequently used before surgical procedures with the intent of targetting and reducing the number of bacteria on the surface of the eye. These bacteria serve as potential sources for post-operative infection. One commonly used method is the administration of antibiotic drops 3 times: 1 hour prior to surgery at intervals of 5 minutes. Studies in the lab have shown that the preservative benzalkonium chloride 0.005%, part of the Zymar antibiotic drop preparation, allows the antibiotic to act more effectively than the antibiotic Vigamox, which does not include this preservative.
Comparison: The effect of Zymar antibiotic eye drops on conjunctival cultures compared to the effect of Vigamox on conjunctival cultures as measured by conjunctival cultures taken prior to treatment and then one hour after administration of eye drops 3 times, at 5 minute intervals.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Prospective Study Comparing the Effectiveness of Zymar and Vigamox for Preoperative Antibiotic Sterilization of the Ocular Surface After Loading Dose|
|Study Start Date :||June 2006|
|Study Completion Date :||June 2006|
- Evidence of growth and number of colonies of bacteria on chocolate agar prior to antibiotic administration, t=0 hrs
- Evidence of growth and number of colonies of bacteria on blood agar prior to antibiotic administration, t=0 hrs
- Evidence of growth and number of colonies of bacteria on chocolate agar post-antibiotic administration, t=1 hr
- Evidence of growth and number of colonies of bacteria on blood agar post-antibiotic administration, t=1 hr
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347828
|United States, Massachusetts|
|Ophthalmic Consultants of Boston|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||Michael B Raizman, B.A./M.D.||Ophthalmic Consultants of Boston|
|Study Director:||Sandra Y Cho, B.A./M.D.||New England Eye Center/Tufts-New England Medical Center|
|Study Director:||Rahul Mandiga, B.S.||New England Eye Center/Tufts-New England Medical Center|